| Methods, systems and equipment for the treatment of inflammatory diseases … |
2023-6-08 |
2023-6-30 |
|
| Tl1a patient selection methods, systems, and devices |
2023-2-13 |
2023-8-31 |
|
| Therapeutic agents targeting gpr35 |
2023-1-20 |
2023-5-18 |
|
| Methods of treating inflammatory diseases with combination of tl1a inhibitors … |
2023-1-06 |
2023-7-13 |
|
| Optimized anti-tl1a antibodies |
2022-9-09 |
2023-6-22 |
|
| Anti-cd30l antibodies and uses thereof |
2022-8-26 |
2023-3-02 |
|
| Compositions comprising humanized antibodies to tnf-like ligand 1a (tl1a) and … |
2022-7-26 |
2023-2-02 |
|
| Humanized antibodies against tnf-like ligand 1a (tl1a) and uses thereof |
2022-5-20 |
2022-5-31 |
|
| Humanized antibodies against tnf-like ligand 1a (tl1a) and uses thereof |
2022-4-22 |
2023-1-06 |
|
| Anti-tl1a antibody compositions and methods of treatment in the lung |
2022-2-17 |
2023-1-16 |
|
| Compositions comprising humanized antibodies to tnf-like ligand 1a (tl1a) and … |
2022-2-17 |
2022-8-25 |
|
| Compositions comprising humanized antibodies to tnf-like ligand 1a (tl1a) and … |
2022-2-17 |
2022-8-25 |
|
| Anti-tl1a antibody compositions and methods of treatment in the lung |
2022-2-17 |
2022-8-25 |
|
| COMPOSITIONS COMPRISING HUMANIZED ANTIBODIES AGAINST TNF-TYPE 1A (TL1A) LIGANDS … |
2022-2-17 |
2023-5-17 |
|
| COMPOSITIONS OF ANTI-TL1A ANTIBODIES AND METHODS OF TREATMENT IN THE LUNG |
2022-2-17 |
2023-5-17 |
|
| METHODS, SYSTEMS AND EQUIPMENT FOR THE TREATMENT OF INFLAMMATORY DISEASES … |
2021-11-12 |
2023-2-08 |
|
| Gpr35 modulators |
2021-7-22 |
2021-9-30 |
|
| GPR35 MODULATORS |
2020-1-24 |
2021-9-01 |
|
| Method of disease activity profiling for individual therapy management |
2020-1-17 |
2020-6-25 |
|
| Assessment and monitoring of mucosal healing in children and adults with … |
2019-12-03 |
2020-6-11 |
|
| Methods for prediction of anti-tnf alpha drug levels and autoantibody formation |
2019-11-18 |
2020-5-21 |
|
| Indirect homogeneous mobility shift assays for the detection of biologics in … |
2019-8-09 |
2020-3-19 |
|
| Assays for the detection of anti-tnf drugs and autoantibodies |
2019-7-02 |
2020-1-16 |
|
| Methods and systems for selection and treatment of patients with inflammatory … |
2019-4-26 |
2022-2-16 |
|
| Compositions and methods of targeting gpr35 for the treatment of inflammatory … |
2019-4-26 |
2020-4-16 |
|
| Methods for monitoring vedolizumab treatment |
2018-10-09 |
2020-5-07 |
|
| Addressable antibody arrays and methods of use |
2018-7-16 |
2018-11-08 |
|
| Pathway specific markers for diagnosing irritable bowel syndrome |
2018-6-29 |
2019-7-02 |
2019-7-02 |
| Methods for assessing mucosal healing in crohn's disease patients |
2018-5-31 |
2021-12-14 |
2021-12-14 |
| Gate for controlling oncoming traffic on a roadway |
2018-5-16 |
2020-4-09 |
|
| Methods for establishing a vedolizumab dosing regimen to treat patients with … |
2017-5-22 |
2019-6-18 |
2019-6-18 |
| Antibodies against serotonin, tryptophan and kynurenine metabolites and uses … |
2017-5-05 |
2017-8-24 |
|
| Methods for predicting clinical outcomes in subjects afflicted with ulcerative … |
2017-4-11 |
2017-8-03 |
|
| Her2delta16 peptides |
2017-3-21 |
2017-10-19 |
|
| Flavor concentrates with a fluid texture based on two starches |
2016-9-16 |
2020-6-29 |
2020-6-29 |
| Assays for detecting neutralizing autoantibodies to biologic therapy |
2016-9-01 |
2017-6-22 |
|
| Biomarker panel for assessment of mucosal healing |
2016-7-18 |
2017-1-12 |
|
| Packaging machine |
2016-6-21 |
2020-7-01 |
2020-7-01 |
| Heat management for food processor |
2016-6-15 |
2021-6-23 |
2021-6-23 |
| Signaling pathways in tissues from inflammatory bowel disease patients |
2016-6-02 |
2016-12-08 |
|
| Methods for predicting post-operative recurrence of Crohn's disease |
2016-5-20 |
2020-6-30 |
2020-6-30 |
| System to monitor and alert users to DHA levels |
2016-1-07 |
2020-7-02 |
2020-7-02 |
| Methods for predicting and monitoring mucosal healing |
2015-4-03 |
2015-12-10 |
|
| Antibodies to microbiome, stress factors and mast cell markers as diagnostic … |
2015-3-30 |
2019-1-22 |
2019-1-22 |
| Methods for improving inflammatory bowel disease diagnosis |
2014-3-28 |
2015-3-12 |
|
| Methods for diagnosing irritable bowel syndrome |
2014-3-21 |
2016-11-01 |
2016-11-01 |
| Compositions and methods for detecting allelic variants |
2014-2-18 |
2016-12-06 |
2016-12-06 |
| Methods for identifying inflammatory bowel disease patients with dysplasia or … |
2013-12-10 |
2014-6-26 |
|
| Performance of a biomarker panel for irritable bowel syndrome |
2013-11-04 |
2014-5-22 |
|
| Assays for detecting autoantibodies to anti-tnfalpha drugs |
2013-8-07 |
2014-2-13 |
|
| Citrullinated peptides for diagnosing and prognosing rheumatoid arthritis |
2013-7-26 |
2014-6-19 |
|
| Methods for diagnosing irritable bowel syndrome |
2013-5-09 |
2014-2-20 |
|
| Methods for determining anti-drug antibody isotypes |
2013-4-17 |
2013-12-26 |
|
| Mobility shift assays for detecting anti-tnf alpha drugs and autoantibodies |
2013-4-09 |
2013-11-07 |
|
| Assay for detecting neutralizing autoantibodies to biologic therapy |
2013-3-13 |
2013-10-10 |
|
| Mobility shift assays for detecting anti-tnf alpha drugs and autoantibodies … |
2013-3-12 |
2014-2-20 |
|
| Methods for Optimizing Clinical Responsiveness to Methotrexate Therapy Using … |
2013-1-25 |
2013-5-23 |
|
| Methods of Predicting Methotrexate Efficacy and Toxicity |
2012-12-10 |
2013-6-06 |
|
| Methods for improving inflammatory bowel disease diagnosis |
2012-11-27 |
2013-8-08 |
|
| Novel genomic biomarkers for irritable bowel syndrome diagnosis |
2012-5-23 |
2013-1-03 |
|
| Methods for diagnosing irritable bowel syndrome |
2012-4-06 |
2012-12-13 |
|
| Extensional viscosity to promote safe swallowing of food boluses |
2012-3-01 |
2020-7-03 |
2020-7-03 |
| Inflammatory bowel disease prognostics |
2011-10-27 |
2012-7-05 |
|
| Assays and methods for the detection of Crohn's disease |
2011-7-25 |
2013-5-21 |
2013-5-21 |
| Methods of Quantifying Methotrexate Metabolites |
2011-6-10 |
2011-10-27 |
|
| Methods of diagnosing inflammatory bowel disease |
2010-12-10 |
2012-11-20 |
2012-11-20 |
| Inflammatory bowel disease prognostics |
2010-8-05 |
2011-2-24 |
|
| Methods for predicting methotrexate polyglutamate levels using pharmacogenetics |
2010-2-02 |
2010-8-12 |
|
| Methods of diagnosing tissue fibrosis |
2010-1-27 |
2010-12-16 |
|
| Methods for prediction of inflammatory bowel disease (ibd) using serologic … |
2009-11-10 |
2010-5-27 |
|
| Methods to predict risk for celiac disease by detecting anti-flagellin antibody … |
2009-2-25 |
2013-4-02 |
2013-4-02 |
| Methods for diagnosing irritable bowel syndrome |
2008-10-16 |
2010-4-15 |
|
| Addressable antibody arrays and methods of use |
2008-9-12 |
2009-3-26 |
|
| Methods and agents for evaluating inflammatory bowel disease, and targets for … |
2008-3-26 |
2010-7-01 |
|
| Methods for diagnosing irritable bowel syndrome |
2008-3-05 |
2014-4-01 |
2014-4-01 |
| Crohn disease susceptibility gene |
2007-7-26 |
2010-4-22 |
|
| Method and system for assisting in diagnosing irritable bowel syndrome |
2007-2-26 |
2011-5-17 |
2011-5-17 |
| Methods of diagnosing inflammatory bowel disease |
2006-11-30 |
2017-2-21 |
2017-2-21 |
| Method for optimizing thiopurine efficacy and toxicity using mass spectrometry |
2005-11-14 |
2006-9-28 |
|
| Methods of diagnosing inflammatory bowel disease |
2005-5-11 |
2006-1-05 |
|
| Systems and methods for monitoring chemical and biolgical activities using … |
2004-4-23 |
2004-11-11 |
|
| Systems and methods for monitoring chemical and biological activities using … |
2004-3-11 |
2010-5-11 |
2010-5-11 |
| Method of determining thiopurine methyltransferase activity |
2003-5-02 |
2006-11-21 |
2006-11-21 |
| Methods for direct detection of individual methotrexate metabolites |
2003-3-07 |
2005-7-26 |
2005-7-26 |
| Methods of diagnosing liver fibrosis |
2003-2-28 |
2010-12-21 |
2010-12-21 |